Want to join the conversation?
In February 2015, $REGN and Sanofi entered into an amended ZALTRAP agreement under which Sanofi is solely responsible for the development and commercialization of ZALTRAP Injection for Intravenous Infusion for cancer indications worldwide. Sanofi bears the cost of all development & commercialization activities and reimburses $REGN for its costs.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!